Diagnosis and Treatment of Lung Neuroendocrine Neoplasms Somatostatin Receptor PET Imaging and Peptide Receptor Radionuclide Therapy

被引：2
|
作者：
Park, Hyesun [1 ]
Subramaniam, Rathan M. [2 ,3 ]
机构：
[1] Lahey Hosp, Med Ctr, Dept Radiol, 41 Burlington Mall Rd, Burlington, MA 01850 USA
[2] Univ Otago Sch Med, Dept Med, 01 Great King St, Dunedin 9016, New Zealand
[3] Duke Univ, Dept Radiol, Davison Bldg, Durham, NC 27710 USA
来源：
PET CLINICS | 2023年 / 18卷 / 02期
关键词：
Lung carcinoid; Somatostatin receptor PET imaging; Peptide receptor radionuclide therapy; CARCINOID TUMORS; PULMONARY; SURVIVAL; EFFICACY; LU-177-DOTATATE; EVEROLIMUS; RADIANT-4; CONSENSUS; SPECT/CT;
D O I：
10.1016/j.cpet.2022.11.005
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：223 / 231
页数：9
相关论文
共 50 条
  • [31] Management of neuroendocrine tumours of the rectum (rNET) with Ga-68 somatostatin receptor PET/CT (SR-PET/CT) and Peptide Receptor Radionuclide Therapy (PRRT)
    Prasad, V.
    Kaemmerer, D.
    Hommann, M.
    Hoersch, D.
    Zachert, C.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S201 - S201
  • [32] Ga-68 somatostatin receptor PET/CT (SR-PET/CT) and peptide receptor radionuclide therapy (PRRT) for management of neuroendocrine tumors of the rectum (rNET)
    Prasad, V.
    Kaemmerer, D.
    Hoersch, D.
    Hommann, M.
    Zachert, C.
    Baum, R. P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [33] Therapy-Related Myeloid Neoplasms in Patients with Neuroendocrine Neoplasms after Peptide Receptor Radionuclide Therapy: A Systematic Review
    Sonbol, M.
    Hilal, T.
    Halfdanarson, T.
    [J]. NEUROENDOCRINOLOGY, 2020, 110 : 105 - 105
  • [34] SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN NEUROENDOCRINE NEOPLASMS
    ANTHONY, LB
    MARTIN, W
    ARILDSEN, R
    SHAFF, M
    CLANTON, J
    DELBEKE, D
    SANDLER, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 174 - 174
  • [35] Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumours
    Alsadik, Shahad
    Yusuf, Siraj
    AL-Nahhas, Adil
    [J]. CURRENT RADIOPHARMACEUTICALS, 2019, 12 (02) : 126 - 134
  • [36] Peptide Receptor Radionuclide Therapy in Rectal Neuroendocrine Tumours
    Tham, W. Y. A.
    Huang, H. L.
    Tai, W. M. D.
    Yan, X. S.
    Ng, C. E. D.
    Loke, S. H. K.
    [J]. NEUROENDOCRINOLOGY, 2020, 110 : 275 - 275
  • [37] Theranostics with Ga-68 Somatostatin Receptor PET/CT Monitoring Response to Peptide Receptor Radionuclide Therapy
    Kulkarni, Harshad R.
    Baum, Richard P.
    [J]. PET CLINICS, 2014, 9 (01) : 91 - +
  • [38] Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Bodei, Lisa
    Cremonesi, Marta
    Kidd, Mark
    Grana, Chiara M.
    Severi, Stefano
    Modlin, Irvin M.
    Paganelli, Giovanni
    [J]. THORACIC SURGERY CLINICS, 2014, 24 (03) : 333 - +
  • [39] Cure of Neuroendocrine Carcinoma by Peptide Receptor Radionuclide Therapy
    Zoephel, Klaus
    Strumpf, Annette
    Wunderlich, Gerd
    Oehme, Liane
    Eisenhofer, Graeme
    Kotzerke, Joerg
    [J]. CLINICAL NUCLEAR MEDICINE, 2008, 33 (10) : 690 - 691
  • [40] Editorial: peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
    Pommier, Rodney F.
    [J]. SURGERY, 2018, 163 (04) : 768 - 769
12345